CONSTELLATION TECHNOLOGIES LIMITED — Remuneration Information 2007

Dec 19, 2007

==> picture [112 x 91] intentionally omitted <==

20 December 2007

REMUNERATION DETAILS OF NEW CEO

As announced earlier today, the Agenix Board has appointed Dr Stephen Phua, MBBS, MFPM, as Chief Executive Officer and Managing Director effective from 3 January 2008.

Dr Phua will be based in Singapore but will spend considerable time visiting the Agenix China operations.

Dr Phua has been employed under a 2-year contract commencing 3 January 2008. His remuneration package consists of the following:

• a cash salary of A$400,000

• potential bonuses of a further A$225,000 based on the achievement of operational goals and share price performance.

• Dr Phua will be based in Singapore and taxed as a Singaporean resident. If for any reason Australian income tax is levied, which the Board has been advised will not be the case, the company will reimburse Dr Phua for any amount above Singapore resident tax rates.

• The provision of a car and a driver.

• The payment of family medical and dental expenses.

• The issue of 5 million options, as an incentive to accept the role of CEO and Managing Director with the company, with an exercise price of 16 cents (the closing price of Agenix shares on the deemed effective date of the contract).

• Participation in the company employee option scheme with option grants of 500,000 options on 21 July 2008 and 500,000 options on 21 July 2009 with exercise prices calculated as the average closing share price of Agenix shares for the 20 trading days prior to each grant date.

• 6 months’ notice is required.

• If the contract is terminated early with no breach of the conditions of employment by the employee then the company will be required to make a lump sum payment equivalent to the sum of:

  • 12 months’ fixed remuneration plus average bonus previously paid,

  • unused annual and other statutory leave,

  • an amount equal to the Black Scholes valuation of unexercised options issued to the employee.

ENDS

For more information contact:

Mr Ravi Govindan Chairman Agenix Limited Ph: +65 9878 1233